New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways

Molecules. 2021 Jan 14;26(2):410. doi: 10.3390/molecules26020410.

Abstract

Acute myeloid leukemia (AML) is a cancer of the myeloid lineage of blood cells, and treatment for AML is lengthy and can be very expensive. Medicinal plants and their bioactive molecules are potential candidates for improving human health. In this work, we studied the effect of Ptychotis verticillata (PV) essential oil and its derivatives, carvacrol and thymol, in AML cell lines. We demonstrated that a combination of carvacrol and thymol induced tumor cell death with low toxicity on normal cells. Mechanistically, we highlighted that different molecular pathways, including apoptosis, oxidative, reticular stress, autophagy, and necrosis, are implicated in this potential synergistic effect. Using quantitative RT-PCR, Western blotting, and apoptosis inhibitors, we showed that cell death induced by the carvacrol and thymol combination is caspase-dependent in the HL60 cell line and caspase-independent in the other cell lines tested. Further investigations should focus on improving the manufacturing of these compounds and understanding their anti-tumoral mechanisms of action. These efforts will lead to an increase in the efficiency of the oncotherapy strategy regarding AML.

Keywords: AML-cancer therapy; apoptotic and non-apoptotic pathways; bioactive molecules; cell death; drug combination-synergy.

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Antineoplastic Agents / pharmacology*
  • Apoptosis*
  • Cell Proliferation
  • Cymenes / pharmacology*
  • Drug Synergism
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / pathology
  • Thymol / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Cymenes
  • Thymol
  • carvacrol